HF
IMGN

HRT Financial’s Immunogen Inc IMGN Stock Holding History

HRT Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-322,121
Closed -$6.08M – 3333
2023
Q2 		$6.08M Buy
+322,121
New +$3.8M 0.06% 235
2022
Q4 		– Sell
-361,353
Closed -$1.73M – 3413
2022
Q3 		$1.73M Buy
+361,353
New +$1.9M 0.02% 661
2022
Q1 		– Sell
-42,731
Closed -$317K – 4071
2021
Q4 		$317K Sell
42,731
-154,406
-78% -$960K ﹤0.01% 2232
2021
Q3 		$1.12M Buy
+197,137
New +$1.14M 0.01% 1158
2021
Q2 		– Sell
-51,578
Closed -$417K – 3700
2021
Q1 		$417K Buy
+51,578
New +$421K ﹤0.01% 1921
2019
Q3 		– Sell
-95,505
Closed -$207K – 1657
2019
Q2 		$207K Buy
+95,505
New +$226K 0.01% 624

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial's IMGN Position: Q3 2023 in Review

HRT Financial sold out of Immunogen Inc (IMGN) in Q3 2023, closing a stake of 322,121 shares — an estimated $6.08M sold.

HRT Financial first reported a position in IMGN in Q2 2019 and held it in 6 quarters. The position peaked at $6.08M in Q2 2023. 275 funds tracked by Wall St. Rank hold IMGN as of Q3 2023.

  • HRT Financial reported no remaining Immunogen Inc position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 322,121 Immunogen Inc shares in Q3 2023, an estimated $6.08M.
  • HRT Financial first reported a position in Immunogen Inc in Q2 2019 and held it in 6 quarters.
  • HRT Financial's Immunogen Inc position peaked at $6.08M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.